Astrana Health, Inc. (ASTH)
| Market Cap | 1.70B |
| Revenue (ttm) | 3.18B |
| Net Income (ttm) | 22.49M |
| Shares Out | 49.47M |
| EPS (ttm) | 0.46 |
| PE Ratio | 75.07 |
| Forward PE | 26.69 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 309,202 |
| Open | 34.01 |
| Previous Close | 34.01 |
| Day's Range | 33.57 - 34.94 |
| 52-Week Range | 18.08 - 34.94 |
| Beta | 0.77 |
| Analysts | Strong Buy |
| Price Target | 34.86 (+1.47%) |
| Earnings Date | May 7, 2026 |
About ASTH
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients prima... [Read more]
Financial Performance
In 2025, Astrana Health's revenue was $3.18 billion, an increase of 56.39% compared to the previous year's $2.03 billion. Earnings were $22.49 million, a decrease of -47.89%.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for ASTH stock is "Strong Buy." The 12-month stock price target is $34.86, which is an increase of 1.47% from the latest price.
News
Astrana Health, Inc. Schedules 2026 First Quarter Financial Results Release and Conference Call
ALHAMBRA, Calif., April 21, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, techno...
Astrana Health, Inc. to Participate in Upcoming Investor Conferences
ALHAMBRA, Calif., April 10, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, techno...
Astrana Health Transcript: Barclays 28th Annual Global Healthcare Conference
Record growth and profitability continue, with strong guidance for 2024 and 2025. Membership trends reflect industry headwinds, but efficiency, conservative risk adjustment, and AI-driven operations support resilience and margin stability.
Foothill Regional Medical Center Receives 2026 Patient Safety Excellence Award™ from Healthgrades
Recognition places Foothill Regional among the top 5% in the nation for patient safety TUSTIN, Calif., March 10, 2026 /PRNewswire/ -- Foothill Regional Medical Center, part of Astrana Health, Inc. (NA...
Astrana Health Earnings Call Transcript: Q4 2025
Record 2025 results with 56% revenue growth, strong cash flow, and margin expansion driven by disciplined risk management, technology leverage, and successful Prospect integration. 2026 guidance reflects conservative assumptions and continued growth across markets.
Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results
Company to Host Conference Call on Monday, March 2, 2026, at 5:30 a.m. PT/8:30 a.m.
Astrana Health Stock Slide Presents An Attractive Entry Point: Analyst
Astrana Health Inc. (NASDAQ: ASTH) stock on Tuesday fell around 22% to close at $21.48.
Astrana Health, Inc. Schedules 2025 Fourth Quarter and Year-End Financial Results Release and Conference Call
ALHAMBRA, Calif., Jan. 26, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, ...
Astrana Health Transcript: 44th Annual J.P. Morgan Healthcare Conference
A scalable delegated risk platform is driving growth through technology, full-risk contracts, and strategic acquisitions, with a focus on Medicare Advantage and operational efficiency. The model delivers strong outcomes, high retention, and positions the organization as a preferred partner amid regulatory shifts.
Astrana Health, Inc. to Participate in Upcoming Investor Conference
ALHAMBRA, Calif., Jan. 6, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technolo...
Astrana Health Earnings Call Transcript: Q3 2025
Q3 2025 saw revenue double year-over-year and strong EBITDA growth, driven by the Prospect Health acquisition and organic expansion. Updated 2025 guidance reflects a timing delay in full-risk contracts, with margin expansion and synergy realization expected in 2026.
Astrana Health, Inc. Reports Third Quarter 2025 Results
Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m.
Astrana Health, Inc. Schedules 2025 Third Quarter Financial Results Release and Conference Call
ALHAMBRA, Calif. , Oct. 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric,...
Astrana Health Earnings Call Transcript: Q2 2025
Q2 2025 saw 35% revenue growth to $654.8M and strong adjusted EBITDA, driven by full-risk contracts and Care Partners. Prospect Health acquisition closed at a lower price, improving leverage, with integration and synergy targets on track. Medicaid and exchange headwinds are seen as manageable.
Astrana Health, Inc. Reports Second Quarter 2025 Results
Company to Host Conference Call on Thursday, August 7, 2025, at 2:30 p.m. PT/5:30 p.m.
Astrana Health, Inc. Schedules 2025 Second Quarter Financial Results Release and Conference Call
ALHAMBRA, Calif. , July 22, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric,...
Astrana Health Announces Closing of Prospect Health Acquisition
ALHAMBRA, Calif. , July 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technol...
Astrana Health Transcript: 45th Annual William Blair Growth Stock Conference
A unique centralized network model has driven rapid, profitable growth and industry-leading efficiency, with expansion into new markets and successful acquisitions. Proprietary AI technology and a focus on full risk arrangements support continued strong financial and clinical outcomes.
Astrana Health Strengthens Leadership Team to Scale AI-Enabled Healthcare Delivery Platform for All
ALHAMBRA, Calif. , June 3, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technol...
Astrana Health Transcript: Bank of America 2025 Healthcare Conference
A value-based healthcare network is expanding through the $745M Prospect Health acquisition, adding 14,000 providers and 600,000 patients, with integration supported by prior experience and robust technology. Confident in 2025 and 2027 EBITDA guidance, the company sees manageable risks in Medicare and Medicaid and expects significant growth in California.
Astrana Health Earnings Call Transcript: Q1 2025
Q1 2025 saw 53% revenue growth to $620.4M and strong adjusted EBITDA, driven by membership expansion and value-based care. CHS integration is complete, Prospect Health acquisition is on track, and full-year guidance remains unchanged despite sector headwinds.
Astrana Health, Inc. Reports First Quarter 2025 Results
Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m.
Astrana Health Transcript: TD Cowen 45th Annual Healthcare Conference
2025 guidance projects $2.5–$2.7 billion revenue and $170–$190 million EBITDA, excluding Prospect Health, whose acquisition is expected to add $1.2 billion revenue and $81 million EBITDA. Focus is on integration, operational efficiencies, and prudent risk management, with a $350 million+ EBITDA target for 2027.